Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain
- PMID: 12351696
- DOI: 10.1210/me.2001-0033
Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain
Abstract
Prolactin (PRL)-dependent signaling occurs as the result of ligand-induced homodimerization of the PRL receptor (PRLr). To date, short, intermediate, and long human PRLr isoforms have been characterized. To investigate the expression of other possible human PRLr isoforms, RT-PCR was performed on mRNA isolated from the breast carcinoma cell line T47D. A 1.5-kb PCR fragment was isolated, subcloned, and sequenced. The PCR product exhibited a nucleotide sequence 100% homologous to the human long isoform except bp 71-373 were deleted, which code for the S1 motif of the extracellular domain. Therefore, this isoform was designated the deltaS1 PRLr. Northern analysis revealed variable deltaS1 PRLr mRNA expression in a variety of tissues. Transfection of Chinese hamster ovary cells with deltaS1 cDNA showed the isoform is expressed at the protein level on the cell surface with a molecular mass of approximately 70 kDa. Kinetic studies indicated the deltaS1 isoform bound ligand at a lower affinity than wild-type receptor. The deltaS1 PRLr was also shown to activate the proximal signaling molecule Jak2 upon addition of ligand to transfected cells, and, unlike the long PRLr, high concentrations of ligand did not function as a self-antagonist to signaling during intervals of PRL serum elevation, i.e. stress and pregnancy. Given its apparent widespread expression, this PRLr isoform may contribute to PRL action. Furthermore, the functionality of this receptor raises interesting questions regarding the minimal extracellular domain necessary for ligand-induced receptor signaling.
Similar articles
-
Functional characterization of the intermediate isoform of the human prolactin receptor.J Biol Chem. 1999 Dec 10;274(50):35461-8. doi: 10.1074/jbc.274.50.35461. J Biol Chem. 1999. PMID: 10585417
-
Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.Mol Endocrinol. 2006 Nov;20(11):2734-46. doi: 10.1210/me.2006-0114. Epub 2006 Jul 13. Mol Endocrinol. 2006. PMID: 16840534
-
N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting.Mol Endocrinol. 1998 Apr;12(4):544-55. doi: 10.1210/mend.12.4.0085. Mol Endocrinol. 1998. PMID: 9544990
-
New mechanisms for PRLr action in breast cancer.Trends Endocrinol Metab. 2009 Jul;20(5):223-9. doi: 10.1016/j.tem.2009.03.001. Epub 2009 Jun 15. Trends Endocrinol Metab. 2009. PMID: 19535262 Review.
-
Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.Endocr Rev. 1998 Jun;19(3):225-68. doi: 10.1210/edrv.19.3.0334. Endocr Rev. 1998. PMID: 9626554 Review.
Cited by
-
Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.Horm Cancer. 2014 Feb;5(1):42-50. doi: 10.1007/s12672-013-0165-7. Epub 2013 Nov 19. Horm Cancer. 2014. PMID: 24249584 Free PMC article.
-
S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain.Biochemistry. 2008 Jan 8;47(1):479-89. doi: 10.1021/bi7013882. Epub 2007 Dec 15. Biochemistry. 2008. PMID: 18081308 Free PMC article.
-
The human intermediate prolactin receptor is a mammary proto-oncogene.NPJ Breast Cancer. 2021 Mar 26;7(1):37. doi: 10.1038/s41523-021-00243-7. NPJ Breast Cancer. 2021. PMID: 33772010 Free PMC article.
-
Molecular mechanisms of prolactin and its receptor.Endocr Rev. 2012 Aug;33(4):504-25. doi: 10.1210/er.2011-1040. Epub 2012 May 10. Endocr Rev. 2012. PMID: 22577091 Free PMC article. Review.
-
The role of prolactin in mammary carcinoma.Endocr Rev. 2003 Feb;24(1):1-27. doi: 10.1210/er.2001-0036. Endocr Rev. 2003. PMID: 12588805 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous